Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine
神经母细胞瘤患者接受 (131)I-间碘苄胍治疗后继发性恶性肿瘤的发生率和危险因素
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2016.07.017
Huibregtse, Kelly E; Vo, Kieuhoa T; DuBois, Steven G; Fetzko, Stephanie; Neuhaus, John; Batra, Vandana; Maris, John M; Weiss, Brian; Marachelian, Araz; Yanik, Greg A; Matthay, Katherine K
